LeukoDx and GE Healthcare Enter Agreement to Explore Solutions for Cell Characterization in Cell Therapy Manufacturing
March 16, 2016 10:00 ET
|
LeukoDx;GE Healthcare
JERUSALEM, ISRAEL--(Marketwired - March 16, 2016) -
LeukoDx, an emerging leader in the field of fully-automated cell-based assays, and GE Healthcare's Life Sciences business, a provider of...
LeukoDx Promoting Rapid Diagnosis and Treatment of Sepsis on World Sepsis Day 2015
September 13, 2015 09:00 ET
|
LeukoDx
TOWSON, MD and JERUSALEM, ISRAEL--(Marketwired - Sep 13, 2015) - LeukoDx, developers of a compact device for diagnosing life-threatening sepsis, is joining doctors, hospitals, healthcare systems,...
LeukoDx Chosen as a 2015 Red Herring Europe Winner
April 27, 2015 09:00 ET
|
LeukoDx
TOWSON, MD and JERUSALEM, ISRAEL--(Marketwired - Apr 27, 2015) - Red Herring announced its Red Herring Europe award winners, recognizing Europe's leading private companies and celebrating these...
LeukoDx Inc. Announces Appointment of Dr. Tobias Volker as Senior Vice President for Commercial Operations
April 21, 2015 09:00 ET
|
LeukoDx
TOWSON, MD and JERUSALEM, ISRAEL--(Marketwired - Apr 21, 2015) - LeukoDx Inc., an emerging leader in the field of innovative medical diagnostic technology, announced today the appointment of Dr....
LeukoDx Inc. Chosen as a 2015 Red Herring Top 100 Europe Finalist
March 24, 2015 09:00 ET
|
LeukoDx
TOWSON, MD and JERUSALEM, ISRAEL--(Marketwired - Mar 24, 2015) - LeukoDx Inc., the creator of the Accellix automated flow cytometry platform, announced today that it has been selected as a Finalist...
LeukoDx Inc. Receives European CE Mark Approval and ISO Certification for Accellix(TM)
January 27, 2015 09:00 ET
|
LeukoDx
TOWSON, MD and JERUSALEM, ISRAEL--(Marketwired - Jan 27, 2015) - LeukoDx Inc., an emerging leader in the field of innovative medical diagnostic technology, today announced that it has completed all...
LeukoDx Inc. Announces Appointment of Dr. Ephraim Carlebach as Senior Vice President R&D
September 30, 2014 08:00 ET
|
LeukoDx
TOWSON, MD and JERUSALEM, ISRAEL--(Marketwired - Sep 30, 2014) - LeukoDx Inc., the creator of the Accellix automated flow cytometry platform, today announced the appointment of Ephraim Carlebach,...
LeukoDx Inc. Closes $7M Financing Round; Appoints Seymour Liebman & Mark Chess to BOD
June 16, 2014 09:00 ET
|
LeukoDx
TOWSON, MD and JERUSALEM, ISRAEL--(Marketwired - Jun 16, 2014) - LeukoDx Inc., the creator of the Accellix automated flow cytometry platform, today announced that it has secured $7 million in new...
LeukoDx Inc. Reaches Key Prototype Milestone, Closes on the Second Tranche of $2 Million as Part of Its $8 Million in Funding Commitment
November 08, 2012 11:38 ET
|
LeukoDx
TOWSON, MD and JERUSALEM--(Marketwire - Nov 8, 2012) - LeukoDx Inc. is pleased to announce it has reached a significant milestone by completing the development of a functional alpha prototype of...
LeukoDx Receives Third Year Chief Scientist Grant for 50% of $1.15 Million R&D Budget
May 15, 2012 10:00 ET
|
LeukoDx
JERUSALEM--(Marketwire - May 15, 2012) - LeukoDx Ltd. is pleased to announce that it has secured approval for a grant from the Office of the Chief Scientist in Israel for the third year. The...